RT
Rick Tsai
Chief Executive Officer at LUCA Science Inc.
Greater Tokyo Area
Overview
Rick Tsai is the CEO of LUCA Science Inc., with a background in medicine and pharmaceuticals. He has held significant leadership roles at companies like Merck and Allergan, demonstrating expertise in clinical development, drug development, and medical affairs.
Tsai's career highlights include serving as the Vice Chairman of the Medical Affairs Committee Japan at PhRMA and leading regulatory affairs at Merck. His current role as CEO at LUCA Science Inc. showcases his strong leadership skills and experience in the biotechnology and healthcare sectors.
Work Experience
Chief Executive Officer
2020 - Current
Venture Partner
2020
Vice Chairman Medical Affairs Committee Japan
2016 - 2020
Head of Medical Affairs / Executive Officer MSD KK / Associate Vice President
2012 - 2020
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Raised $5,586,000.00 from Private Capital Advisors.
Medical Director Japan, Taiwan & Hong Kong
2011 - 2012
Repros Therapeutics is focused on the development of new drugs to treat hormonal and reproductive system disorders.
Raised $29,499,310.00 from New Enterprise Associates.
Senior Director, Head of Regulatory Affiars, Japan Development
2006 - 2011
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Raised $5,586,000.00 from Private Capital Advisors.
Associate Surgeon
2005 - 2006
Resident
1999 - 2005
Oral and Maxillofacial Surgery
NYP Ventures strives to identify and support digital health innovations to improve care quality and patient experience.
Education
Doctor of Medicine (MD)
2000 - 2002
Certificate
1993 - 1994